Concepedia

LBA60 ZENITH20, a multinational, multi-cohort phase II study of poziotinib in NSCLC patients with EGFR or HER2 exon 20 insertion mutations

Mark A. Socinski, Robin Cornelissen, Marina Chiara Garassino, Jeffrey Clarke, N. Simon Tchekmedyian, Julian R. Molina, J.W. Goldman, Gajanan Bhat, François Lebel, Xiuning Le

Annals of Oncology · 2020 · 41 citations · 0 references

DOI

Concepts